Unlock instant, AI-driven research and patent intelligence for your innovation.

Composition and preparation method of SeZn7MT3 and application thereof in preventing and treating Alzheimer's disease

A technology of metallothionein and selenogenesis, applied in the field of biomedicine, can solve problems such as synaptic function damage and destruction of synapse-related protein functions

Pending Publication Date: 2017-09-08
LIAOCHENG CITY ORIENT BIOMEDICAL TECH CO LTD
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

If these systems function abnormally, or the amount of ROS exceeds the load of the system, the accumulated ROS will destroy the function of synapse-related proteins by attacking molecules such as proteins and lipids, causing damage to synapse function

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition and preparation method of SeZn7MT3 and application thereof in preventing and treating Alzheimer's disease
  • Composition and preparation method of SeZn7MT3 and application thereof in preventing and treating Alzheimer's disease
  • Composition and preparation method of SeZn7MT3 and application thereof in preventing and treating Alzheimer's disease

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] Example 1: SeZn 7 Preparation of MT3

[0016] All biochemical reagents and kits were purchased from Sigama or Invitrogen unless otherwise specified.

[0017] (1) Smt-MT3 plasmid construction

[0018] Human metallothionein MT3 and fusion tag protein gene Smt3 were purchased from Guangzhou Funeng Gene Company. The gene carrier plasmid MBPHT-mCherry-2 was purchased from Invitrogen, and the gene primer synthesis was completed by Shanghai Jereh Biotechnology Co., Ltd., using the designed primers P1, P2 (to amplify the Smt3 gene) and P3, P4 (to amplify the MT3 gene) to amplify out the PCR product. The amplified products were detected and verified by 1% agarose gel, and the correct fragments were recovered from the gel. Product 1 and product 2 were mixed at the same concentration ratio as a template, and the Smt3-MT3 sequence was amplified using primers P1 and P4, with a BamH I restriction site GGATCC at its 5' end and a Hind III restriction site at its 3' end Site AAGCTT...

Embodiment 2

[0035] Embodiment 2: Alzheimer's disease mouse model and SeZn 7 Drug efficacy test of MT3

[0036] C57 ordinary mice, male, weighing 24-26 g, 5 months old, SPF grade, were purchased from Shanghai Slack Experimental Animal Co., Ltd. [Experimental animal quality certificate number: SCXK (Shanghai) 2007-0005]. APP / PS1 transgenic mice were purchased from Beijing Zhongke Zesheng Biotechnology Co., Ltd., 5 months old, weighing 24-26g. All mice were free to forage and drink, and were kept at room temperature (23±2)°C. Feed and water were all processed by autoclaving, and all experimental feeding processes were SPF grade. The experimental mice were randomly divided into 3 groups, 10 mice in each group. A: normal C57 mice group, B: APP / PS1 transgenic mice, negative control group (normal saline group); C: SeZn7MT3 administration group, APP / PS1 transgenic mice.

[0037] Test drug name: SeZn 7 MT3;

[0038] Solvent: normal saline;

[0039] Preparation method: Prepare the solution w...

Embodiment 3

[0041] Example 3: Using the Morris water maze to verify the cognitive ability of Alzheimer's mice

[0042] The experimental mice were randomly divided into two groups, with 10 mice in each group. A: APP / PS1 transgenic mice; B: SeZn 7 MT3 administration group, APP / PS1 transgenic mice.

[0043]Device: a circular pool with a diameter of 1m, a height of 50cm, and a water depth of 30cm. The bottom of the pool is white, and the water temperature is kept at 23±2°C. Four equidistant points N, E, S, and W are marked on the pool wall as the starting point of the test. The pool has four quadrants, and a platform is placed in the center of the third quadrant (the distance between the platform and the center of the pool wall is equal); it is submerged 1 cm below the water, so that the platform is invisible. There are abundant reference clues around the pool (triangles, squares, circles, and rhombuses of different colors are placed in each quadrant) and remain unchanged for the mice to us...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of biological medicine, and discloses SeZn7MT3 innovatively constituent metal protein and a high-efficiency preparation method thereof, and through a biotechnology and chemical synthesis combined method, SeZn7MT3 can be efficiently prepared. Shown by study of the invention, the SeZn7MT3 can improve the cognition and memory functions of a model rat with Alzheimer's disease, regulate and improve the morphology of AD brain hippocampus cells, inhibit nerve cell apoptosis, inhibit amyloid deposit, and effectively prevent the development of Alzheimer's disease. Consequently, the SeZn7MT3 has important application prospects in preventing and treating the Alzheimer's disease.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, in particular to SeZn 7 The chemical composition and preparation method of MT3's innovative metalloprotein, and its application in the prevention and treatment of Alzheimer's disease and the preparation of anti-Alzheimer's disease and other neurodegenerative disease drugs. Background technique [0002] Alzheimer's Disease (AD), commonly known as senile dementia, was first reported by German scholar Alosi Alzheimer in 1907. This is a primary degenerative disease of the central nervous system that often occurs in the elderly. At present, there are more than 50 million AD patients in the world. Its clinical manifestations are memory loss, language difficulties, and disorientation in varying degrees. , decreased cognitive ability, abnormal personality, behavior and emotional activities, progressive mental retardation, and finally systemic failure, concurrent infection and death. Currently AD ha...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/825C12N15/70A61K38/18A61P25/18
CPCA61K38/00C07K14/825
Inventor 谭瀛轩向道凤张跃茹谭相石
Owner LIAOCHENG CITY ORIENT BIOMEDICAL TECH CO LTD